Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Anderson

Showing results (161-170 of 271) with videos related to

Pageof 28
Sort By:
The Journal of Infectious Diseases|April 4, 2019
Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIVMary Morrow, Samantha MaWhinney, Ryan P Coyle, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2020
Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIVRyan P Coyle, Mary Morrow, Stacey S Coleman, et al.
Journal of Clinical Pharmacology|December 17, 2011
Influence of SLCO1B1 polymorphisms on the drug-drug interaction between darunavir/ritonavir and pravastatinChristina L Aquilante, Jennifer J Kiser, Peter L Anderson, et al.
The Journal of Antimicrobial Chemotherapy|May 14, 2019
Increased tenofovir monoester concentrations in patients receiving tenofovir disoproxil fumarate with ledipasvir/sofosbuvirKristina M Brooks, Jose R Castillo-Mancilla, Joshua Blum, et al.
AIDS (London, England)|May 18, 2021
Improving adherence to daily preexposure prophylaxis among MSM in Amsterdam by providing feedback via a mobile applicationMark A M van den Elshout, Elske Hoornenborg, Roel C A Achterbergh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2015
Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individualsJose R Castillo-Mancilla, Amie Meditz, Cara Wilson, et al.
The Journal of Infectious Diseases|June 14, 2015
Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and TenofovirCharles W Dobard, Andrew Taylor, Sunita Sharma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 9, 2014
Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measuresSanjiv M Baxi, Albert Liu, Peter Bacchetti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 16, 2024
Hepatitis B virus (HBV) viremia despite tenofovir disoproxil fumarate-containing antiretroviral therapy in persons with HBV/HIV coinfectionPatrick Ryan, Elizabeth Odegard, Heidi Meeds, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2016
Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV SuppressionJose R Castillo-Mancilla, Todd T Brown, Kristine M Erlandson, et al.
Pageof 28

Showing results (161-170 of 271) with videos related to

Sort By:
Pageof 28
The Journal of Infectious Diseases|April 4, 2019
Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIVMary Morrow, Samantha MaWhinney, Ryan P Coyle, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2020
Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIVRyan P Coyle, Mary Morrow, Stacey S Coleman, et al.
Journal of Clinical Pharmacology|December 17, 2011
Influence of SLCO1B1 polymorphisms on the drug-drug interaction between darunavir/ritonavir and pravastatinChristina L Aquilante, Jennifer J Kiser, Peter L Anderson, et al.
The Journal of Antimicrobial Chemotherapy|May 14, 2019
Increased tenofovir monoester concentrations in patients receiving tenofovir disoproxil fumarate with ledipasvir/sofosbuvirKristina M Brooks, Jose R Castillo-Mancilla, Joshua Blum, et al.
AIDS (London, England)|May 18, 2021
Improving adherence to daily preexposure prophylaxis among MSM in Amsterdam by providing feedback via a mobile applicationMark A M van den Elshout, Elske Hoornenborg, Roel C A Achterbergh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2015
Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individualsJose R Castillo-Mancilla, Amie Meditz, Cara Wilson, et al.
The Journal of Infectious Diseases|June 14, 2015
Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and TenofovirCharles W Dobard, Andrew Taylor, Sunita Sharma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 9, 2014
Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measuresSanjiv M Baxi, Albert Liu, Peter Bacchetti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 16, 2024
Hepatitis B virus (HBV) viremia despite tenofovir disoproxil fumarate-containing antiretroviral therapy in persons with HBV/HIV coinfectionPatrick Ryan, Elizabeth Odegard, Heidi Meeds, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2016
Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV SuppressionJose R Castillo-Mancilla, Todd T Brown, Kristine M Erlandson, et al.
Pageof 28